Publications by authors named "Pierre Leconte"

Claim this Profile
P
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study.
Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz, Takashi Oshima, Nina Karaseva, Pierre Leconte

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.
Eric X Chen, Petr Kavan, Mustapha Tehfe, Jeremy S Kortmansky, Michael B Sawyer, Pierre Leconte

Clin Colorectal Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D.
Richard Kim, Mustapha Tehfe, Petr Kavan, Jorge Chaves, Jeremy S Kortmansky, Pierre Leconte

Clin Colorectal Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer.
Thierry André, Filippo Pietrantonio, Antonio Avallone, Mahmut Gumus, Lucjan Wyrwicz, Pierre Leconte

Future Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.
Dung T Le, Luis A Diaz, Tae Won Kim, Eric Van Cutsem, Ravit Geva, Pierre Leconte

Eur J Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of chemotherapy-based therapies for previously treated advanced colorectal cancer: a systematic literature review and meta-analysis.
Mayur M Amonkar, Lauren A Abderhalden, Andrew M Frederickson, Audrone Aksomaityte, Brian M Lang, Pierre Leconte

Int J Colorectal Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of relapsed or refractory follicular lymphoma patients in daily practice - a French non-interventional study.
Pierre Feugier, Pauline Brice, Marc Maynadié, Patricia Franchi-Rezgui, Maya Hacini, Pierre Leconte

Leuk Lymphoma· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study on the management of patients with rituximab refractory follicular lymphoma.
Philippe Solal-Céligny, Pierre Leconte, Aurélie Bardet, Juana Hernandez, Xavier Troussard

Br J Haematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study.
Driss Chaoui, Sylvain Choquet, Laurence Sanhes, Béatrice Mahé, Maya Hacini, Pierre Leconte

Leuk Lymphoma· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diurnal autonomic variations and emotional reactivity.
Pascal Hot, Pierre Leconte, Henrique Sequeira

Biol Psychol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis